Cargando...

Canada's New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem

Alberta, quickly followed by other Canadian provinces, has introduced a new pricing model for generic drugs, in which prices are inversely related to the number of generic manufacturers of the drug. This paper examines the rationale for the new policy.

Guardado en:
Detalles Bibliográficos
Publicado en:Healthc Policy
Autores principales: Hollis, Aidan, Grootendorst, Paul
Formato: Artigo
Lenguaje:Inglês
Publicado: Longwoods Publishing 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748362/
https://ncbi.nlm.nih.gov/pubmed/26571465
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!